Surgery Partners - 10 Year Stock Price History | SGRY
- The all-time high Surgery Partners stock closing price was 67.05 on June 25, 2021.
- The Surgery Partners 52-week high stock price is 35.30, which is 38.5% above the current share price.
- The Surgery Partners 52-week low stock price is 19.50, which is 23.5% below the current share price.
- The average Surgery Partners stock price for the last 52 weeks is 27.29.
Surgery Partners Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 21.6295 | 21.2900 | 25.7500 | 19.8500 | 25.4900 | 20.41% |
2024 | 28.1520 | 31.6300 | 35.0700 | 19.6100 | 21.1700 | -33.82% |
2023 | 33.8881 | 26.3000 | 45.0900 | 22.3200 | 31.9900 | 14.82% |
2022 | 37.7983 | 55.0700 | 61.6900 | 22.3000 | 27.8600 | -47.84% |
2021 | 47.3017 | 27.6000 | 67.0500 | 27.6000 | 53.4100 | 84.11% |
2020 | 17.0142 | 16.3100 | 29.0100 | 4.6800 | 29.0100 | 85.31% |
2019 | 10.2402 | 10.0800 | 15.9900 | 5.5200 | 15.6550 | 59.91% |
2018 | 15.4343 | 13.3500 | 19.8000 | 9.7900 | 9.7900 | -19.09% |
2017 | 15.9499 | 15.5000 | 23.6500 | 7.6500 | 12.1000 | -23.66% |
2016 | 16.3423 | 19.4900 | 20.7400 | 12.1000 | 15.8500 | -22.65% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $3.273B | $2.743B |
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $92.839B | 12.14 |
Cencora (COR) | United States | $49.468B | 18.60 |
DiDi Global (DIDIY) | China | $22.650B | 0.00 |
Natera (NTRA) | United States | $22.209B | 0.00 |
ICON (ICLR) | Ireland | $16.344B | 14.56 |
Revvity (RVTY) | United States | $15.033B | 26.11 |
Avantor (AVTR) | United States | $14.626B | 21.93 |
BioMerieux (BMXMF) | France | $14.203B | 0.00 |
Viatris (VTRS) | United States | $13.523B | 4.17 |
CochLear (CHEOY) | Australia | $12.916B | 0.00 |
Solventum (SOLV) | United States | $12.870B | 0.00 |
Doximity (DOCS) | United States | $10.767B | 63.37 |
Medpace Holdings (MEDP) | United States | $10.662B | 30.04 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
HealthEquity (HQY) | United States | $9.429B | 47.30 |
Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
Organon (OGN) | United States | $4.079B | 4.11 |
Sotera Health (SHC) | United States | $3.875B | 20.73 |
Concentras Parent (CON) | United States | $2.998B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
Premier (PINC) | United States | $2.191B | 11.40 |
Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
PACS (PACS) | United States | $2.080B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
Progyny (PGNY) | United States | $1.980B | 40.09 |
GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
Agilon Health (AGL) | United States | $1.413B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
CareDx (CDNA) | United States | $1.210B | 0.00 |
Embecta (EMBC) | United States | $1.070B | 7.48 |
AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
SBC Medicals (SBC) | United States | $0.518B | 0.00 |
InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
DocGo (DCGO) | United States | $0.490B | 18.46 |
QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
Enhabit (EHAB) | United States | $0.422B | 36.52 |
COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
MultiPlan (MPLN) | United States | $0.267B | 0.00 |
LifeMD (LFMD) | United States | $0.248B | 0.00 |
Nutex Health (NUTX) | United States | $0.243B | 0.00 |
Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
Beauty Health (SKIN) | United States | $0.205B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
Biodesix (BDSX) | United States | $0.151B | 0.00 |
So-Young (SY) | China | $0.105B | 17.83 |
Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
ModivCare (MODV) | United States | $0.066B | 3.57 |
Oncology Institute (TOI) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
OncoCyte (OCX) | United States | $0.034B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
KindlyMD (KDLY) | United States | $0.008B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |